| Belleville Healthcare And Rehabilitation Center | |
| 2626 Wesleyan Dr, Belleville, Kansas 66935 | |
| (785) 527-5636 | |
| Name | Belleville Healthcare And Rehabilitation Center |
|---|---|
| Location | 2626 Wesleyan Dr, Belleville, Kansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 62 |
| Occupancy Rate | 46.45% |
| Medicare ID (CCN) | 175246 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1124205901 |
| Organization Name | HMG PARK MANOR OF BELLEVILLE, LLC |
| Doing Business As | BELLEVILLE HEALTH CARE CENTER |
| Address | 2626 Wesleyan Dr, Belleville, KS 66935 |
| Phone Number | 785-527-5636 |
News Archive
With one simple experiment, University of Illinois chemists have debunked a widely held misconception about an often-prescribed drug.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented this afternoon as an oral communication at a late breaking forum of the American Gastroenterological Association Institute during Digestive Disease Week 2010 in New Orleans, Louisiana.
Life Technologies Corporation, a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation for $450 million in cash, subject to a conventional working capital adjustment.
Meditation and deep breathing techniques, as a form of relaxation, have been in use for thousands of years. However, in the unique new book Pranayama (published by AuthorHouse), author Dr. Ravinder Jerath presents explanations and illustrations to more easily and succinctly explain exactly how meditation and deep breathing techniques beneficially affect the human body.
› Verified 6 days ago
| NPI Number | 1437748720 |
| Organization Name | BELLEVILLE HEALTHCARE AND REHABILITATION CENTER LLC |
| Doing Business As | BELLEVILLE HEALTHCARE AND REHABILITATION CENTER |
| Address | 2626 Wesleyan Dr, Belleville, KS 66935 |
| Phone Number | 785-527-5636 |
News Archive
With one simple experiment, University of Illinois chemists have debunked a widely held misconception about an often-prescribed drug.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented this afternoon as an oral communication at a late breaking forum of the American Gastroenterological Association Institute during Digestive Disease Week 2010 in New Orleans, Louisiana.
Life Technologies Corporation, a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation for $450 million in cash, subject to a conventional working capital adjustment.
Meditation and deep breathing techniques, as a form of relaxation, have been in use for thousands of years. However, in the unique new book Pranayama (published by AuthorHouse), author Dr. Ravinder Jerath presents explanations and illustrations to more easily and succinctly explain exactly how meditation and deep breathing techniques beneficially affect the human body.
› Verified 6 days ago
| NPI Number | 1801899000 |
| Organization Name | WESTVIEW MANOR HEALTH CARE ASSOCIATES INC |
| Doing Business As | BELLEVILLE HEALTH CARE CENTER |
| Address | 2626 Wesleyan Dr, Belleville, KS 66935 |
| Phone Number | 785-527-5636 |
News Archive
With one simple experiment, University of Illinois chemists have debunked a widely held misconception about an often-prescribed drug.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented this afternoon as an oral communication at a late breaking forum of the American Gastroenterological Association Institute during Digestive Disease Week 2010 in New Orleans, Louisiana.
Life Technologies Corporation, a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation for $450 million in cash, subject to a conventional working capital adjustment.
Meditation and deep breathing techniques, as a form of relaxation, have been in use for thousands of years. However, in the unique new book Pranayama (published by AuthorHouse), author Dr. Ravinder Jerath presents explanations and illustrations to more easily and succinctly explain exactly how meditation and deep breathing techniques beneficially affect the human body.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
With one simple experiment, University of Illinois chemists have debunked a widely held misconception about an often-prescribed drug.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented this afternoon as an oral communication at a late breaking forum of the American Gastroenterological Association Institute during Digestive Disease Week 2010 in New Orleans, Louisiana.
Life Technologies Corporation, a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation for $450 million in cash, subject to a conventional working capital adjustment.
Meditation and deep breathing techniques, as a form of relaxation, have been in use for thousands of years. However, in the unique new book Pranayama (published by AuthorHouse), author Dr. Ravinder Jerath presents explanations and illustrations to more easily and succinctly explain exactly how meditation and deep breathing techniques beneficially affect the human body.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $7216 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 35.29 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.13 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.25 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.4 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.94 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.45 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.1 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.36 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.93 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.89 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.32 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.13 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.49 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.42 | 95.98 |